Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OLMESARTAN MEDOXOMIL vs OMACETAXINE MEPESUCCINATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OLMESARTAN MEDOXOMIL vs OMACETAXINE MEPESUCCINATE: Safety Overview

Metric OLMESARTAN MEDOXOMIL OMACETAXINE MEPESUCCINATE
Total FAERS Reports 11,972 957
Deaths Reported 283 94
Death Rate 2.4% 9.8%
Hospitalizations 6,564 316
Average Patient Age 66.9 yrs 53.3 yrs
% Female Patients 56.6% 50.0%
FDA Approval Date Apr 13, 2020 Oct 26, 2012
Manufacturer direct rx N/A
Route ORAL N/A
Marketing Status Prescription Discontinued